A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
Status:
Active, not recruiting
Trial end date:
2022-03-05
Target enrollment:
Participant gender:
Summary
The primary hypothesis of this study is that hyper-radiosensitivity (HRS) seen at extremely
low doses of radiation can be exploited to enhance the effect of chemotherapy, and that this
effect differs from the cellular effect of higher, standard fractions of radiation used in
traditional radiation treatment paradigms.